HuGE Literature Finder
Records
1
-
10
Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome. Journal of personalized medicine 2023 2 13 (2): . Ho Teresa T, Noble Melissa, Tran Bao Anh, Sunjic Katlynd, Gupta Sheeba Varghese, Turgeon Jacques, Crutchley Rustin |
Valproic Acid After Neurosurgery Induces Elevated Risk of Liver Injury: A Prospective Nested Case-Control Study. The Annals of pharmacotherapy 2021 Nov 10600280211055508. Guo Jinlin, Ma Jiuhong, Wang Shan, Li Xingang, Ji Hongming, Li Yuanping, Peng Fangchen, Sun Yi |
CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study. Acta neurologica Belgica 2020 Jul . Eltalal Samah, El Ayouty Mostafa, El-Said Afaf, Wahba Yah |
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. Pharmacogenomics and personalized medicine 2018 4 11 51-58. Silvado Carlos Eduardo, Terra Vera Cristina, Twardowschy Carlos Alexand |
Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury. Scandinavian journal of trauma, resuscitation and emergency medicine 2017 Aug 25 (1): 85. Sun Yirui, Yu Jian, Yuan Qiang, Wu Xing, Wu Xuehai, Hu J |
The effect of polymorphic metabolism enzymes on serum phenytoin level. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2015 Mar 36 (3): 397-401. Ozkaynakci Aydan, Gulcebi Medine Idrizoglu, Ergeç Deniz, Ulucan Korkut, Uzan Mustafa, Ozkara Cigdem, Guney Ilter, Onat Filiz Yilm |
Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures. Archives of disease in childhood 2012 Jun 97 (6): 569-72. Lee Soon Min, Chung Jae Yong, Lee Young Mock, Park Min Soo, Namgung Ran, Park Kook In, Lee Ch |
Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment. Pharmacogenomics 2010 Jul 11 (7): 927-41. Grover Sandeep, Gourie-Devi Mandaville, Baghel Ruchi, Sharma Sangeeta, Bala Kiran, Gupta Meena, Narayanasamy Krishnamoorthy, Varma Binuja, Gupta Meenal, Kaur Kavita, Talwar Puneet, Kaur Harpreet, Giddaluru Sudheer, Sharma Abhay, Brahmachari Samir K, Indian Genome Variation Consortium , Kukreti Ritushr |
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients. European journal of clinical pharmacology 2010 Jul 66 (7): 689-96. Kesavan Ramasamy, Narayan Sunil K, Adithan Chandrasekar |
Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy. Seizure 2010 Mar 19 (2): 93-101. Sánchez M Blanca, Herranz José L, Leno Carlos, Arteaga Rosa, Oterino Agustín, Valdizán Elsa M, Nicolás José M, Adín Javier, Armijo Juan |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: